Doha, March 15 (QNA) - Sidra Medicine and Hamad Medical Corporation (HMC) have jointly established a new pediatric orthopedic oncology surgery service.
The service is the first of its kind to be offered to children and young people diagnosed with primary bone or soft tissue cancer including benign and cancerous tumors. The multidisciplinary service is also the first of its kind to be offered in the State of Qatar for children and young people.
In addition to pediatric orthopedic oncology surgery, the service is supported by other sub-specialties such as diagnostic and interventional radiology, pathology, medical and radiation oncology, physiotherapy and occupational therapy and is available at both Sidra Medicine and HMC's Bone and Joint Centre.
Dr. Talal Ibrahim, Division Chief of Pediatric Orthopedic Surgery at Sidra Medicine said: "Most children with bone cancer often end up seeing multiple doctors as they undergo different tests, surgeries and treatment programs including chemotherapy or radiation. This means they require expertise from both orthopedic and oncology surgeons. By joining forces with our counterparts at Hamad Medical Corporation, our patients will benefit from both specialties and treated at either facility to ensure they receive the highest level of care." Dr. Ahmed Mounir, Senior Consultant Orthopedic Oncology at Hamad Medical Corporation said: "A smooth, simple and uninterrupted pathway of diagnosis and treatment for children with suspected or confirmed bone or soft tissue tumors has been established and agreed upon between both Sidra Medicine and Hamad Medical Corporation. This newly established pathway would provide high quality service to these patients by highly experienced physicians and surgeons from both facilities in one place". (QNA)